163 related articles for article (PubMed ID: 29396548)
21. Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.
Ding Q; He X; Hsu JM; Xia W; Chen CT; Li LY; Lee DF; Liu JC; Zhong Q; Wang X; Hung MC
Mol Cell Biol; 2007 Jun; 27(11):4006-17. PubMed ID: 17387146
[TBL] [Abstract][Full Text] [Related]
22. SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation.
Ma Y; Cui D; Xiong X; Inuzuka H; Wei W; Sun Y; North BJ; Zhao Y
Mol Oncol; 2019 Feb; 13(2):307-321. PubMed ID: 30428154
[TBL] [Abstract][Full Text] [Related]
23. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
24. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.
Peng C; Zhu F; Wen W; Yao K; Li S; Zykova T; Liu K; Li X; Ma WY; Bode AM; Dong Z
J Biol Chem; 2012 Jul; 287(31):25881-92. PubMed ID: 22685297
[TBL] [Abstract][Full Text] [Related]
25. Fbxw11 promotes the proliferation of lymphocytic leukemia cells through the concomitant activation of NF-κB and β-catenin/TCF signaling pathways.
Wang L; Feng W; Yang X; Yang F; Wang R; Ren Q; Zhu X; Zheng G
Cell Death Dis; 2018 Apr; 9(4):427. PubMed ID: 29555946
[TBL] [Abstract][Full Text] [Related]
26. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
27. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):34. PubMed ID: 38281999
[TBL] [Abstract][Full Text] [Related]
28. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
Cho YY
Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of processing of the NF-kappa B2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCF(beta-TrCP) ubiquitin ligase.
Amir RE; Haecker H; Karin M; Ciechanover A
Oncogene; 2004 Apr; 23(14):2540-7. PubMed ID: 14676825
[TBL] [Abstract][Full Text] [Related]
30. UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase.
Limón-Mortés MC; Mora-Santos M; Espina A; Pintor-Toro JA; López-Román A; Tortolero M; Romero F
J Cell Sci; 2008 Jun; 121(11):1825-31. PubMed ID: 18460583
[TBL] [Abstract][Full Text] [Related]
31. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
32. Regulation of NF-κB by ubiquitination and degradation of the IκBs.
Kanarek N; Ben-Neriah Y
Immunol Rev; 2012 Mar; 246(1):77-94. PubMed ID: 22435548
[TBL] [Abstract][Full Text] [Related]
33. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
34. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
Shi P; Zhu S; Lin Y; Liu Y; Liu Y; Chen Z; Shi Y; Qian Y
Sci Signal; 2011 Nov; 4(197):ra73. PubMed ID: 22045853
[TBL] [Abstract][Full Text] [Related]
35. Regulation of lung cancer cell growth and invasiveness by beta-TRCP.
He N; Li C; Zhang X; Sheng T; Chi S; Chen K; Wang Q; Vertrees R; Logrono R; Xie J
Mol Carcinog; 2005 Jan; 42(1):18-28. PubMed ID: 15536641
[TBL] [Abstract][Full Text] [Related]
36. Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase.
Asada S; Ikeda A; Nagao R; Hama H; Sudo T; Fukamizu A; Kasuya Y; Kishi T
Int J Mol Med; 2008 Jul; 22(1):95-104. PubMed ID: 18575781
[TBL] [Abstract][Full Text] [Related]
37. Transfer-NMR and docking studies identify the binding of the peptide derived from activating transcription factor 4 to protein ubiquitin ligase beta-TrCP. Competition STD-NMR with beta-catenin.
Pons J; Evrard-Todeschi N; Bertho G; Gharbi-Benarous J; Tanchou V; Benarous R; Girault JP
Biochemistry; 2008 Jan; 47(1):14-29. PubMed ID: 18052253
[TBL] [Abstract][Full Text] [Related]
38. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
[TBL] [Abstract][Full Text] [Related]
40. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.
Wang N; Wang X; Tan HY; Li S; Tsang CM; Tsao SW; Feng Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
